1. Home
  2. MGRM
  3. MGRM News

Latest Monogram Orthopaedics Inc. (MGRM) News on January 19, 2025

MGRM

ACCESSWIRE

a month ago

Monogram Technologies Provides 510(k) Submission Update Following Positive Meeting with FDA

MGRM

ACCESSWIRE

2 months ago

Monogram Technologies Announces Management and Related Parties Complete Open Market Purchases of MGRM Common Stock Totaling $1 Million

MGRM

Zacks Small Cap Research

2 months ago

MGRM: Monogram’s Potential for Profitable Long-Term Growth Supports Price Target of $6.00.

Will Monogram Technologies (NASDAQ:MGRM) Spend Its Cash Wisely?
MGRM

Simply Wall St.

2 months ago

Will Monogram Technologies (NASDAQ:MGRM) Spend Its Cash Wisely?

MGRM

ACCESSWIRE

2 months ago

Monogram Technologies Reports Third Quarter 2024 Financial Results

MGRM

ACCESSWIRE

2 months ago

Monogram Technologies to Host Third Quarter 2024 Results Conference Call on Tuesday, November 19, 2024 at 4:30 p.m. Eastern Time

MGRM

Zacks Small Cap Research

3 months ago

MGRM: Monogram Announces it has Received an Additional Information Request (AIR) from the FDA Regarding its Recent 510(k) Submission.

Monogram Technologies Named Orthopedic Joint Replacement Company of the Year 2024
MGRM

ACCESSWIRE

3 months ago

Monogram Technologies Named Orthopedic Joint Replacement Company of the Year 2024

MGRM

ACCESSWIRE

3 months ago

Monogram Technologies to Present at the LD Micro Main Event XVII Conference on Wednesday October 30, 2024

MGRM

ACCESSWIRE

4 months ago

CORRECTION FROM SOURCE: Monogram Technologies Issues Correction to Press Release Announcing it Received an FDA Response for its mBôs TKA System

MGRM

ACCESSWIRE

4 months ago

Monogram Technologies Receives FDA Response for mBôs TKA System

MGRM

ACCESSWIRE

4 months ago

Monogram Technologies Announces Closing of Upsized and Oversubscribed $13 Million Public Offering

MGRM

ACCESSWIRE

4 months ago

Monogram Technologies Announces Preferred Stock Dividends

MGRM

ACCESSWIRE

4 months ago

Monogram Technologies Upsizes 8.00% Series D Convertible Cumulative Preferred Stock and Warrant Offering to $12.5 Million

MGRM

Zacks Small Cap Research

5 months ago

MGRM: Monogram’s Potential for Profitable Long-Term Growth Supports Price Target of $6.00

Monogram Technologies Reports Second Quarter 2024 Financial Results
MGRM

ACCESSWIRE

5 months ago

Monogram Technologies Reports Second Quarter 2024 Financial Results

Monogram Technologies Secures Initial Strategic Clinical Trial Collaboration
MGRM

ACCESSWIRE

5 months ago

Monogram Technologies Secures Initial Strategic Clinical Trial Collaboration

Monogram Technologies Submits 510(k) Application for mBôs TKA System Clearance
MGRM

ACCESSWIRE

5 months ago

Monogram Technologies Submits 510(k) Application for mBôs TKA System Clearance

Monogram Technologies to Host Second Quarter 2024 Business Update Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time
MGRM

ACCESSWIRE

6 months ago

Monogram Technologies to Host Second Quarter 2024 Business Update Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time

MGRM

ACCESSWIRE

6 months ago

Monogram Technologies Launches Continuous Offering of 8.00% Convertible Preferred Stock and Warrants

MGRM

Zacks Small Cap Research

7 months ago

MGRM: Monogram’s Potential for Profitable Long-Term Growth Supports Price Target of $6.00

Monogram Technologies to Host Investor and Analyst Tour at its Headquarters in Austin, Texas, on Thursday, June 20th, 2024
MGRM

ACCESSWIRE

8 months ago

Monogram Technologies to Host Investor and Analyst Tour at its Headquarters in Austin, Texas, on Thursday, June 20th, 2024

MGRM

ACCESSWIRE

8 months ago

Monogram Orthopaedics Completes Corporate Name Change to Monogram Technologies

MGRM

ACCESSWIRE

8 months ago

Monogram Orthopaedics Reports First Quarter 2024 Financial Results

MGRM

ACCESSWIRE

8 months ago

Monogram Engages Contract Research Organization to Oversee mBôs Robot Clinical Trial Activities Outside the U.S.

MGRM

ACCESSWIRE

9 months ago

Monogram Provides Regulatory Update Following Meeting with FDA

Is Monogram Orthopaedics (NASDAQ:MGRM) In A Good Position To Invest In Growth?
MGRM

Simply Wall St.

9 months ago

Is Monogram Orthopaedics (NASDAQ:MGRM) In A Good Position To Invest In Growth?

MGRM

ACCESSWIRE

9 months ago

Monogram Accepted to NVIDIA Inception Program

Monogram Orthopaedics, Inc. (NASDAQ:MGRM) Q4 2023 Earnings Call Transcript
MGRM

Insider Monkey

10 months ago

Monogram Orthopaedics, Inc. (NASDAQ:MGRM) Q4 2023 Earnings Call Transcript

When Can We Expect A Profit From Monogram Orthopaedics, Inc. (NASDAQ:MGRM)?
MGRM

Simply Wall St.

10 months ago

When Can We Expect A Profit From Monogram Orthopaedics, Inc. (NASDAQ:MGRM)?

MGRM

ACCESSWIRE

10 months ago

Monogram Orthopaedics to Host Business Update Conference Call on Thursday, March 21st at 5:00 p.m. Eastern Time

MGRM

Zacks Small Cap Research

10 months ago

MGRM: Initiation of medical device company developing a product solution architecture to enable patient-optimized orthopedic implants by linking 3D printing and robotics.

MGRM

ACCESSWIRE

10 months ago

Monogram Orthopaedics Reports Full Year 2023 Financial Results

Monogram Orthopaedics to Present Rescheduled Product Discussion with Surgeon Reaction during AAOS Annual Meeting
MGRM

ACCESSWIRE

a year ago

Monogram Orthopaedics to Present Rescheduled Product Discussion with Surgeon Reaction during AAOS Annual Meeting

Community West Bancshares Reports Full Year Earnings and Declares Quarterly Cash Dividend of $0.08 Per Common Share
MGRM

GlobeNewswire

a year ago

Community West Bancshares Reports Full Year Earnings and Declares Quarterly Cash Dividend of $0.08 Per Common Share

Peoples Bancorp Inc. (NASDAQ:PEBO) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?
MGRM

Simply Wall St.

a year ago

Peoples Bancorp Inc. (NASDAQ:PEBO) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?

MGRM

ACCESSWIRE

a year ago

Monogram Orthopaedics to Present at the Canaccord Genuity Musculoskeletal Conference on February 12, 2024

Investing in Red Violet (NASDAQ:RDVT) five years ago would have delivered you a 155% gain
MGRM

Simply Wall St.

a year ago

Investing in Red Violet (NASDAQ:RDVT) five years ago would have delivered you a 155% gain

Hycroft Delivers More High-Grade - Expands New Silver System at Brimstone
MGRM

PR Newswire

a year ago

Hycroft Delivers More High-Grade - Expands New Silver System at Brimstone

Everspin Technologies, Inc.'s (NASDAQ:MRAM) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
MGRM

Simply Wall St.

a year ago

Everspin Technologies, Inc.'s (NASDAQ:MRAM) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

All-new 2025 INFINITI QX80 to feature premium Klipsch® Reference Premiere Audio System, powered by Panasonic
MGRM

PR Newswire

a year ago

All-new 2025 INFINITI QX80 to feature premium Klipsch® Reference Premiere Audio System, powered by Panasonic

Everspin Technologies Inc CEO Sanjeev Aggarwal Sells 12,242 Shares
MGRM

GuruFocus.com

a year ago

Everspin Technologies Inc CEO Sanjeev Aggarwal Sells 12,242 Shares

MGRM

GlobeNewswire

a year ago

Blue World Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combination

Yunji Announces Appointment of New Independent Director
MGRM

PR Newswire

a year ago

Yunji Announces Appointment of New Independent Director

Insiders own 26% of Monogram Orthopaedics, Inc. (NASDAQ:MGRM) shares but retail investors control 60% of the company
MGRM

Simply Wall St.

a year ago

Insiders own 26% of Monogram Orthopaedics, Inc. (NASDAQ:MGRM) shares but retail investors control 60% of the company

Ellomay Capital Reports Results for the Three and Nine Months Ended September 30, 2023
MGRM

PR Newswire

a year ago

Ellomay Capital Reports Results for the Three and Nine Months Ended September 30, 2023

Oncternal Therapeutics Updates the Status of its Phase 1/2 Study of ONCT-808, a ROR1-Targeting Autologous CAR T, in Patients with Relapsed or Refractory Aggressive B-cell Lymphoma
MGRM

GlobeNewswire

a year ago

Oncternal Therapeutics Updates the Status of its Phase 1/2 Study of ONCT-808, a ROR1-Targeting Autologous CAR T, in Patients with Relapsed or Refractory Aggressive B-cell Lymphoma

Akebia Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
MGRM

PR Newswire

a year ago

Akebia Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

HUB Secures Prestigious Position as Prime Vendor in Major Deal with Top-Tier Israeli Defense Contractor for Advanced Real-Time Battle Computing Solutions
MGRM

GlobeNewswire

a year ago

HUB Secures Prestigious Position as Prime Vendor in Major Deal with Top-Tier Israeli Defense Contractor for Advanced Real-Time Battle Computing Solutions

MGRM

ACCESSWIRE

a year ago

Monogram Orthopaedics to Reschedule Robotic Product Demo Live Stream

Subdued Growth No Barrier To Tango Therapeutics, Inc. (NASDAQ:TNGX) With Shares Advancing 25%
MGRM

Simply Wall St.

a year ago

Subdued Growth No Barrier To Tango Therapeutics, Inc. (NASDAQ:TNGX) With Shares Advancing 25%

Positive week for Adaptimmune Therapeutics plc (NASDAQ:ADAP) institutional investors who lost 68% over the past year
MGRM

Simply Wall St.

a year ago

Positive week for Adaptimmune Therapeutics plc (NASDAQ:ADAP) institutional investors who lost 68% over the past year

MicroAlgo Inc. announced plans to establish a practice base to train graduate students for the university
MGRM

PR Newswire

a year ago

MicroAlgo Inc. announced plans to establish a practice base to train graduate students for the university

MGRM

Thomson Reuters StreetEvents

a year ago

Q3 2023 Lands End Inc Earnings Call

Lands' End (LE) Q3 2023 Earnings Call Transcript
MGRM

Motley Fool

a year ago

Lands' End (LE) Q3 2023 Earnings Call Transcript

Lavie Bio Announces a Distribution Agreement with WinField United Canada for its Bio-Inoculant Seed Treatment Yalos™
MGRM

PR Newswire

a year ago

Lavie Bio Announces a Distribution Agreement with WinField United Canada for its Bio-Inoculant Seed Treatment Yalos™

US Army Awards Nearly $20 Million Contract Extension to Gilat to Sustain Anytime, Anywhere Satellite Connectivity
MGRM

GlobeNewswire

a year ago

US Army Awards Nearly $20 Million Contract Extension to Gilat to Sustain Anytime, Anywhere Satellite Connectivity

Altimmune Announces Positive Topline Results from MOMENTUM 48-Week Phase 2 Obesity Trial of Pemvidutide
MGRM

GlobeNewswire

a year ago

Altimmune Announces Positive Topline Results from MOMENTUM 48-Week Phase 2 Obesity Trial of Pemvidutide

MGRM

ACCESSWIRE

a year ago

Monogram Orthopaedics to Host Robotic Product Demo Live Stream on Thursday, December 14, 2023 at 11:00 a.m. Eastern Time

MGRM

ACCESSWIRE

a year ago

Monogram Orthopaedics Delivers First Surgical Robot

Investors in Civista Bancshares (NASDAQ:CIVB) have unfortunately lost 31% over the last year
MGRM

Simply Wall St.

a year ago

Investors in Civista Bancshares (NASDAQ:CIVB) have unfortunately lost 31% over the last year

Will Monogram Orthopaedics (NASDAQ:MGRM) Spend Its Cash Wisely?
MGRM

Simply Wall St.

a year ago

Will Monogram Orthopaedics (NASDAQ:MGRM) Spend Its Cash Wisely?

Flexible Solutions (FSI) Q3 Earnings and Sales Miss Estimates
MGRM

Zacks

a year ago

Flexible Solutions (FSI) Q3 Earnings and Sales Miss Estimates

Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Q3 2023 Earnings Call Transcript
MGRM

Insider Monkey

a year ago

Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Q3 2023 Earnings Call Transcript

Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) Q3 2023 Earnings Call Transcript
MGRM

Insider Monkey

a year ago

Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) Q3 2023 Earnings Call Transcript

MGRM

Thomson Reuters StreetEvents

a year ago

Q3 2023 Arcadia Biosciences Inc Earnings Call

MGRM

Associated Press Finance

a year ago

Arcadia Biosciences: Q3 Earnings Snapshot

Arcadia Biosciences (RKDA) Announces Strong Third Quarter 2023 Financial Results and Business Highlights
MGRM

Business Wire

a year ago

Arcadia Biosciences (RKDA) Announces Strong Third Quarter 2023 Financial Results and Business Highlights

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Q3 2023 Earnings Call Transcript
MGRM

Insider Monkey

a year ago

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Q3 2023 Earnings Call Transcript

Share on Social Networks: